Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients
Open Access
- 19 September 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 116 (3), 563-570
- https://doi.org/10.1007/s10549-008-0181-4
Abstract
Purpose Established models (Penn, Myraid and BRCApro) are useful of estimating the probability that a person has a BRCA mutation. But the value of these models in Chinese population is unclear. The aim of the study is to evaluate the performance of three models on the assisting in pre-test genetic risk counseling. Methods Three risk assessment models, Penn II, Myriad and BRCApro, were applied to 212 familial breast cancer patients who had undergone BRCA1/2 mutation analysis. Sensitivity, specificity, positive and negative predictive values, likelihood ratios and area under the receiver operator characteristic (ROC) curve were calculated for each model. Results Myriad showed a better ROC curve than BRCApro either for BRCA1 or BRCA1/2 combination mutation prediction, but BRCApro had a higher positive likelihood ratio when using 10% as the probability threshold. The performance of three models improved when they were evaluated in 66 patients from high risk families, presenting increased ROC and positive likelihood ratio. Especially that of BRCApro for BRCA2, the ROC was increased to 0.716 and its positive likelihood was 5.6. Conclusion Three models had the similar impact on the pre-test probability of BRCA mutation. But at a 10% cutoff point, BRCApro had the best BRCA mutation carrier prediction value. The performance of BRCApro for BRCA2 mutation prediction was improved when it was restricted in patients from high risk families.Keywords
This publication has 28 references indexed in Scilit:
- The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identifiedBreast Cancer Research and Treatment, 2007
- Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian familiesJournal of Medical Genetics, 2004
- Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 IndividualsJournal of Clinical Oncology, 2002
- A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genesBritish Journal of Cancer, 2002
- The Breast Cancer Information Core: Database design, structure, and scopeHuman Mutation, 2000
- BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast CancerNew England Journal of Medicine, 1997
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990